Know Labs, Inc. (NYSEAMERICAN:KNW – Get Free Report) shares traded up 3.8% during trading on Wednesday. The company traded as high as $2.17 and last traded at $2.1390. 612,050 shares were traded during trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.
Know Labs Stock Performance
The stock has a market capitalization of $16.04 million, a price-to-earnings ratio of -0.33 and a beta of 1.83. The business has a 50-day moving average of $2.14 and a 200-day moving average of $2.14.
About Know Labs
Know Labs, Inc develops non-invasive diagnostic and monitoring technologies designed to analyze materials and biological information using electromagnetic spectroscopy. The company’s platform is intended to identify and measure substances without requiring traditional blood draws or other invasive sampling methods.
Know Labs has focused primarily on non-invasive glucose monitoring for people with diabetes and other users who need to track blood glucose levels. Its principal products and development programs include the KnowU wearable glucose monitor and the UBand, a wrist-worn device designed to collect measurements through the company’s spectroscopy technology.
See Also
- Five stocks we like better than Know Labs
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.
